Hematological Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

InnoPharma Approved

InnoPharma has announced that it has received approval on its ANDA for Decitabine for Injection, a generic version of Eisai's Dacogen.

Myelofibrosis Drug: Orphan Status

Promedior announced that the FDA has granted Orphan Drug designation for PRM-151 for the treatment of myelofibrosis.

First Treatment for Common Anemia

A recent study has demonstrated potential for lexaptepid pegol as the first treatment for anemia of inflammation, the most common form of anemia.

Sensory Deficits in Myeloma

Treatment-naive patients with multiple myeloma (MM) frequently have sensory deficits.

Blood Transfusions and Silent Stroke

Regular blood transfusion therapy could significantly reduce the incidence of the recurrent cerebral infarcts in children with sickle cell anemia.

Investigational Hem. A Therapy

Baxter announced positive results from its Phase 3 trial of BAX 855, an extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A.

Hematological Reference Values

Review this chart on 'Hematological Reference Values' for quick information when you need it.

New Drug Product: Alprolix

Prevention and control of bleeding in hemophilia B.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Transformative Changes in the Management of Multiple MyelomaExternal web site

This symposium will address practical applications of an individualized approach to management of patients with ...

CME 0.50 Credits

Sign Up for Free e-newsletters